Overview the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 Status: Completed Trial end date: 2020-08-12 Target enrollment: Participant gender: Summary Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC113995 PA•H2O in Healthy Subjects Phase: Phase 1 Details Lead Sponsor: Sunshine Lake Pharma Co., Ltd.